Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Quality in Sport

Is a gluten-free diet sufficient in the treatment of Duhring’s Disease? - A Review
  • Home
  • /
  • Is a gluten-free diet sufficient in the treatment of Duhring’s Disease? - A Review
  1. Home /
  2. Archives /
  3. Vol. 36 (2024) /
  4. Medical Sciences

Is a gluten-free diet sufficient in the treatment of Duhring’s Disease? - A Review

Authors

  • Jakub Zwardoń Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland https://orcid.org/0009-0005-3944-2943
  • Alicja Kapciak National Medical Institute of the Ministry of the Interior and Administration Wołoska 137, 02-507 Warsaw, Poland https://orcid.org/0009-0000-0655-8820
  • Julia Górny Mazovian Bródnowski Hospital, Ludwika Kondratowicza 8, 03-242 Warsaw, Poland https://orcid.org/0009-0008-5363-1590
  • Gabriela Witas Western Mazovia Health Center, Limanowskiego 30, 96-300 Żyrardów, Poland https://orcid.org/0009-0009-2782-6391
  • Artur Hawajski University of Technology and Humanities in Radom, Chrobrego 27, 26-600 Radom, Poland https://orcid.org/0009-0003-7592-2114
  • Natalia Jankowska University of Technology and Humanities in Radom, Chrobrego 27, 26-600 Radom, Poland https://orcid.org/0009-0000-3618-6247
  • Oliwia Kamieniecka Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland https://orcid.org/0009-0003-1660-2735
  • Katarzyna Naja Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland https://orcid.org/0009-0008-6513-6984
  • Adrianna Świerzyńska University of Technology and Humanities in Radom, Chrobrego 27, 26-600 Radom, Poland https://orcid.org/0009-0007-1451-3009

DOI:

https://doi.org/10.12775/QS.2024.36.56447

Keywords

dermatitis herpetiformis, celiac disease, gluten free diet, direct immunofluorescence, dapsone, sulfonamides

Abstract

Introduction
Dermatitis herpetiformis is a chronic autoimmune blistering disease characterized by intensely pruritic,
symmetrically distributed skin lesions and an association with gluten-sensitive enteropathy. Despite advances in
diagnostic methods, delayed diagnosis remains a challenge due to its overlapping features with other dermatoses.
Aim of Study
This study aims to provide a comprehensive overview of the diagnostic methods, associated conditions, and
differential diagnosis of dermatitis herpetiformis, focusing on recent advancements in serological,
histopathological, and immunological testing.
Material and methods
A comprehensive review of the literature on dermatitis herpetiformis was performed using the PubMed database.
Results and Conclusions
Direct immunofluorescence remains the gold standard in diagnosing dermatitis herpetiformis, revealing granular
IgA deposits in the dermal papillae. Histopathological findings are supportive but nonspecific, with early lesions
showing subepidermal vesicles and neutrophilic infiltrates. Serological markers, including anti-TG2 and anti-
TG3 antibodies, provide valuable diagnostic support but exhibit variable sensitivity. HLA-DQ2/DQ8 haplotypes
are present in most dermatitis herpetiformis patients, offering high negative predictive value for exclusion.
Associated autoimmune conditions, such as autoimmune thyroid disease and type 1 diabetes, are prevalent, and
dermatitis herpetiformis patients face an elevated risk of non-Hodgkin lymphoma within the first five years after
diagnosis. The diagnosis of dermatitis herpetiformis relies on a combination of direct immunofluorescence,
serological testing, and clinical features. Increased awareness of dermatitis herpetiformis and its associated
conditions is critical for timely diagnosis and management. Advances in immunological and genetic testing may
further refine diagnostic accuracy, while screening for associated autoimmune disorders and malignancies
remains an integral part of patient care.

References

Duhring LA. Landmark article, Aug 30, 1884: Dermatitis herpetiformis. By Louis A. Duhring. JAMA.

;250(2):212-16. doi: 10.1001/jama.250.2.212

Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical

presentation. J Am Acad Dermatol. 2011;64(6):1017-24; quiz 25-6. doi: 10.1016/j.jaad.2010.09.777

Collin P, Salmi TT, Hervonen K, Kaukinen K, Reunala T. Dermatitis herpetiformis: a cutaneous manifestation

of coeliac disease. Ann Med. 2017;49(1):23-31. doi: 10.1080/07853890.2016.1222450

Barnadas MA. Dermatitis Herpetiformis: A Review of Direct Immunofluorescence Findings. Am J

Dermatopathol. 2016;38(4):283-8. doi: 10.1097/DAD.0000000000000420

Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis. Part II. Diagnosis, management, and prognosis. J Am

Acad Dermatol. 2011;64(6):1027-33; quiz 33-4. doi: 10.1016/j.jaad.2010.09.776

Leonard J, Haffenden G, Tucker W, Unsworth J, Swain F, McMinn R, et al. Gluten challenge in dermatitis

herpetiformis. N Engl J Med. 1983;308(14):816-9. doi: 10.1056/NEJM198304073081406

Garioch JJ, Lewis HM, Sargent SA, Leonard JN, Fry L. 25 years' experience of a gluten-free diet in the

treatment of dermatitis herpetiformis. Br J Dermatol. 1994;131(4):541-5. doi: 10.1111/j.1365-

1994.tb08557.x

Savilahti E, Reunala T, Maki M. Increase of lymphocytes bearing the gamma/delta T cell receptor in the

jejunum of patients with dermatitis herpetiformis. Gut. 1992;33(2):206-11. doi: 10.1136/gut.33.2.206

Grainge MJ, West J, Solaymani-Dodaran M, Card TR, Logan RF. The long-term risk of malignancy following

a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study. Aliment Pharmacol Ther.

;35(6):730-9. doi: 10.1111/j.1365-2036.2012.04998.x

Graziano M, Rossi M. An update on the cutaneous manifestations of coeliac disease and non-coeliac gluten

sensitivity. Int Rev Immunol. 2018;37(6):291-300. doi: 10.1080/08830185.2018.1533008

Zhang F, Yang B, Lin Y, Chen S, Zhou G, Wang G, et al. Dermatitis herpetiformis in China: a report of 22

cases. J Eur Acad Dermatol Venereol. 2012;26(7):903-7. doi: 10.1111/j.1468-3083.2011.04204.x

Leffler DA, Green PH, Fasano A. Extraintestinal manifestations of coeliac disease. Nat Rev Gastroenterol

Hepatol. 2015;12(10):561-71. doi: 10.1038/nrgastro.2015.131

Salmi TT, Hervonen K, Kautiainen H, Collin P, Reunala T. Prevalence and incidence of dermatitis

herpetiformis: a 40-year prospective study from Finland. Br J Dermatol. 2011;165(2):354-9. doi: 10.1111/j.1365-

2011.10385.x

West J, Fleming KM, Tata LJ, Card TR, Crooks CJ. Incidence and prevalence of celiac disease and

dermatitis herpetiformis in the UK over two decades: population-based study. Am J Gastroenterol.

;109(5):757-68. doi: 10.1038/ajg.2014.55

Kang JY, Kang AH, Green A, Gwee KA, Ho KY. Systematic review: worldwide variation in the frequency

of coeliac disease and changes over time. Aliment Pharmacol Ther. 2013;38(3):226-45. doi: 10.1111/apt.12373

Salmi TT, Hervonen K, Kurppa K, Collin P, Kaukinen K, Reunala T. Celiac disease evolving into dermatitis

herpetiformis in patients adhering to normal or gluten-free diet. Scand J Gastroenterol. 2015;50(4):387-92. doi:

3109/00365521.2014.974204

Rampertab SD, Pooran N, Brar P, Singh P, Green PH. Trends in the presentation of celiac disease. Am J

Med. 2006;119(4):355 e9-14. doi: 10.1016/j.amjmed.2005.08.044

Spurkland A, Ingvarsson G, Falk ES, Knutsen I, Sollid LM, Thorsby E. Dermatitis herpetiformis and celiac

disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03,

beta 1*0302) heterodimers. Tissue Antigens. 1997;49(1):29-34. doi: 10.1111/j.1399-0039.1997.tb02706.x

Clarindo MV, Possebon AT, Soligo EM, Uyeda H, Ruaro RT, Empinotti JC. Dermatitis herpetiformis:

pathophysiology, clinical presentation, diagnosis and treatment. An Bras Dermatol. 2014;89(6):865-75; quiz 76-

doi: 10.1590/abd1806-4841.20142966

Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, et al. Identification of tissue

transglutaminase as the autoantigen of celiac disease. Nat Med. 1997;3(7):797-801. doi: 10.1038/nm0797-797

Antiga E, Maglie R, Quintarelli L, Verdelli A, Bonciani D, Bonciolini V, et al. Dermatitis Herpetiformis:

Novel Perspectives. Front Immunol. 2019;10:1290. doi: 10.3389/fimmu.2019.01290

Hietikko M, Hervonen K, Ilus T, Salmi T, Huhtala H, Laurila K, et al. Ex vivo Culture of Duodenal Biopsies

from Patients with Dermatitis Herpetiformis Indicates that Transglutaminase 3 Antibody Production Occurs in

the Gut. Acta Derm Venereol. 2018;98(3):366-72. doi: 10.2340/00015555-2849

Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is the

autoantigen of dermatitis herpetiformis. J Exp Med. 2002;195(6):747-57. doi: 10.1084/jem.20011299

Salmi T, Hervonen K. Current Concepts of Dermatitis Herpetiformis. Acta Derm Venereol.

;100(5):adv00056. doi: 10.2340/00015555-3401

Alakoski A, Hervonen K, Mansikka E, Reunala T, Kaukinen K, Kivela L, et al. The Long-Term Safety and

Quality of Life Effects of Oats in Dermatitis Herpetiformis. Nutrients. 2020;12(4). doi: 10.3390/nu12041060

Collin P, Reunala T. Recognition and management of the cutaneous manifestations of celiac disease: a guide

for dermatologists. Am J Clin Dermatol. 2003;4(1):13-20. doi: 10.2165/00128071-200304010-00002

Mistry A, Mistry N. Persistent pruritic papulovesicles. Dermatitis herpetiformis. Am Fam Physician.

;90(6):407-8.

Al-Toma A, Volta U, Auricchio R, Castillejo G, Sanders DS, Cellier C, et al. European Society for the Study

of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European

Gastroenterol J. 2019;7(5):583-613. doi: 10.1177/2050640619844125

Vale E, Dimatos OC, Porro AM, Santi CG. Consensus on the treatment of autoimmune bullous dermatoses:

dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology. An Bras

Dermatol. 2019;94(2 Suppl 1):48-55. doi: 10.1590/abd1806-4841.2019940208

Reunala T, Kosnai I, Karpati S, Kuitunen P, Torok E, Savilahti E. Dermatitis herpetiformis: jejunal findings

and skin response to gluten free diet. Arch Dis Child. 1984;59(6):517-22. doi: 10.1136/adc.59.6.517

Haffenden GP, Blenkinsopp WK, Ring NP, Wojnarowska F, Fry L. The potassium iodide patch test in the

dermatitis herpetiformis in relation to treatment with a gluten-free diet and dapsone. Br J Dermatol.

;103(3):313-7. doi: 10.1111/j.1365-2133.1980.tb07250.x

Hassan S, Dalle S, Descloux E, Balme B, Thomas L. [Dermatitis herpetiformis associated with progesterone

contraception]. Ann Dermatol Venereol. 2007;134(4 Pt 1):385-6. doi: 10.1016/s0151-9638(07)89198-8

Grimwood RE, Guevara A. Leuprolide acetate-induced dermatitis herpetiformis. Cutis. 2005;75(1):49-52.

Marakli SS, Uzun S, Ozbek S, Tuncer I. Dermatitis herpetiformis in a patient receiving infliximab for

ankylosing spondylitis. Eur J Dermatol. 2008;18(1):88-9. doi: 10.1684/ejd.2007.0323

Mochel MC, Ming ME, Imadojemu S, Gangadhar TC, Schuchter LM, Elenitsas R, et al. Cutaneous

autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma. J Cutan

Pathol. 2016;43(9):787-91. doi: 10.1111/cup.12735

Shigeta M, Saiki M, Tsuruta D, Ohata C, Ishii N, Ono F, et al. Two Japanese cases of dermatitis

herpetiformis associated each with lung cancer and autoimmune pancreatitis but showing no intestinal symptom

or circulating immunoglobulin A antibodies to any known antigens. J Dermatol. 2012;39(12):1002-5. doi:

1111/j.1346-8138.2012.01663.x

Fuertes I, Mascaro JM, Bombi JA, Iranzo P. [A retrospective study of clinical, histological, and

immunological characteristics in patients with dermatitis herpetiformis. The experience of Hospital Clinic de

Barcelona, Spain, between 1995 and 2010 and a review of the literature]. Actas Dermosifiliogr.

;102(9):699-705. doi: 10.1016/j.ad.2010.11.007

Zone JJ, Meyer LJ, Petersen MJ. Deposition of granular IgA relative to clinical lesions in dermatitis

herpetiformis. Arch Dermatol. 1996;132(8):912-8. doi:

Hadjivassiliou M, Duker AP, Sanders DS. Gluten-related neurologic dysfunction. Handb Clin Neurol.

;120:607-19. doi: 10.1016/B978-0-7020-4087-0.00041-3

Alonso-Llamazares J, Gibson LE, Rogers RS, 3rd. Clinical, pathologic, and immunopathologic features of

dermatitis herpetiformis: review of the Mayo Clinic experience. Int J Dermatol. 2007;46(9):910-9. doi:

1111/j.1365-4632.2007.03214.x

Rose C, Brocker EB, Zillikens D. Clinical, histological and immunpathological findings in 32 patients with

dermatitis herpetiformis Duhring. J Dtsch Dermatol Ges. 2010;8(4):265-70, -71. doi: 10.1111/j.1610-

2009.07292.x

Bresler SC, Granter SR. Utility of direct immunofluorescence testing for IgA in patients with high and low

clinical suspicion for dermatitis herpetiformis. Am J Clin Pathol. 2015;144(6):880-4. doi:

1309/AJCPXIVSR6OZK1HU

Mansikka E, Hervonen K, Salmi TT, Kautiainen H, Kaukinen K, Collin P, et al. The Decreasing Prevalence

of Severe Villous Atrophy in Dermatitis Herpetiformis: A 45-Year Experience in 393 Patients. J Clin

Gastroenterol. 2017;51(3):235-9. doi: 10.1097/MCG.0000000000000533

Mansikka E, Hervonen K, Kaukinen K, Collin P, Huhtala H, Reunala T, et al. Prognosis of Dermatitis

Herpetiformis Patients with and without Villous Atrophy at Diagnosis. Nutrients. 2018;10(5). doi:

3390/nu10050641

Pasternack C, Kaukinen K, Kurppa K, Maki M, Collin P, Hervonen K, et al. Gastrointestinal Symptoms

Increase the Burden of Illness in Dermatitis Herpetiformis: A Prospective Study. Acta Derm Venereol.

;97(1):58-62. doi: 10.2340/00015555-2471

Caproni M, Antiga E, Melani L, Fabbri P, Italian Group for Cutaneous I. Guidelines for the diagnosis and

treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009;23(6):633-8. doi: 10.1111/j.1468-

2009.03188.x

Araya M, Oyarzun A, Lucero Y, Espinosa N, Perez-Bravo F. DQ2, DQ7 and DQ8 Distribution and Clinical

Manifestations in Celiac Cases and Their First-Degree Relatives. Nutrients. 2015;7(6):4955-65. doi:

3390/nu7064955

Dieterich W, Laag E, Bruckner-Tuderman L, Reunala T, Karpati S, Zagoni T, et al. Antibodies to tissue

transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol.

;113(1):133-6. doi: 10.1046/j.1523-1747.1999.00627.x

Reunala T, Salmi TT, Hervonen K, Laurila K, Kautiainen H, Collin P, et al. IgA antiepidermal

transglutaminase antibodies in dermatitis herpetiformis: a significant but not complete response to a gluten-free

diet treatment. Br J Dermatol. 2015;172(4):1139-41. doi: 10.1111/bjd.13387

Hull CM, Liddle M, Hansen N, Meyer LJ, Schmidt L, Taylor T, et al. Elevation of IgA anti-epidermal

transglutaminase antibodies in dermatitis herpetiformis. Br J Dermatol. 2008;159(1):120-4. doi: 10.1111/j.1365-

2008.08629.x

Sar-Pomian M, Rudnicka L, Olszewska M. Trichoscopy - a useful tool in the preliminary differential

diagnosis of autoimmune bullous diseases. Int J Dermatol. 2017;56(10):996-1002. doi: 10.1111/ijd.13725

Hervonen K, Viljamaa M, Collin P, Knip M, Reunala T. The occurrence of type 1 diabetes in patients with

dermatitis herpetiformis and their first-degree relatives. Br J Dermatol. 2004;150(1):136-8. doi: 10.1111/j.1365-

2004.05642.x

Maglie R, Hertl M. Pharmacological advances in pemphigoid. Curr Opin Pharmacol. 2019;46:34-43. doi:

1016/j.coph.2018.12.007

Varpuluoma O, Jokelainen J, Forsti AK, Timonen M, Huilaja L, Tasanen K. Dermatitis Herpetiformis and

Celiac Disease Increase the Risk of Bullous Pemphigoid. J Invest Dermatol. 2019;139(3):600-4. doi:

1016/j.jid.2018.10.010

Kauppi S, Jokelainen J, Timonen M, Tasanen K, Huilaja L. Atopic Dermatitis Is Associated with Dermatitis

Herpetiformis and Celiac Disease in Children. J Invest Dermatol. 2021;141(1):191-3 e2. doi:

1016/j.jid.2020.05.091

Iyer A, Rathnasabapathi D, Elsone L, Mutch K, Terlizzo M, Footitt D, et al. Transverse myelitis associated

with an itchy rash and hyperckemia: neuromyelitis optica associated with dermatitis herpetiformis. JAMA

Neurol. 2014;71(5):630-3. doi: 10.1001/jamaneurol.2013.6277

Mansikka E, Salmi T, Kaukinen K, Collin P, Huhtala H, Reunala T, et al. Diagnostic Delay in Dermatitis

Herpetiformis in a High-prevalence Area. Acta Derm Venereol. 2018;98(2):195-9. doi: 10.2340/00015555-2818

Mirza HA, Gharbi A, Bhutta BS. Dermatitis Herpetiformis. StatPearls. Treasure Island (FL)2024.

Gorog A, Antiga E, Caproni M, Cianchini G, De D, Dmochowski M, et al. S2k guidelines (consensus

statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of

Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2021;35(6):1251-77. doi:

1111/jdv.17183

Turchin I, Barankin B. Dermatitis herpetiformis and gluten-free diet. Dermatol Online J. 2005;11(1):6. doi:

Paek SY, Steinberg SM, Katz SI. Remission in dermatitis herpetiformis: a cohort study. Arch Dermatol.

;147(3):301-5. doi: 10.1001/archdermatol.2010.336

Mansikka E, Hervonen K, Kaukinen K, Ilus T, Oksanen P, Lindfors K, et al. Gluten Challenge Induces Skin

and Small Bowel Relapse in Long-Term Gluten-Free Diet-Treated Dermatitis Herpetiformis. J Invest Dermatol.

;139(10):2108-14. doi: 10.1016/j.jid.2019.03.1150

Coleman MD. Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. Br

J Dermatol. 1993;129(5):507-13. doi: 10.1111/j.1365-2133.1993.tb00476.x

Wolverton SE, Remlinger K. Suggested guidelines for patient monitoring: hepatic and hematologic toxicity

attributable to systemic dermatologic drugs. Dermatol Clin. 2007;25(2):195-205, vi-ii. doi:

1016/j.det.2007.02.001

Ghaoui N, Hanna E, Abbas O, Kibbi AG, Kurban M. Update on the use of dapsone in dermatology. Int J

Dermatol. 2020;59(7):787-95. doi: 10.1111/ijd.14761

Fry L, Seah PP, Riches DJ, Hoffbrand AV. Clearance of skin lesions in dermatitis herpetiformis after gluten

withdrawal. Lancet. 1973;1(7798):288-91. doi: 10.1016/s0140-6736(73)91539-0

Reunala T, Hervonen K, Salmi T. Dermatitis Herpetiformis: An Update on Diagnosis and Management. Am

J Clin Dermatol. 2021;22(3):329-38. doi: 10.1007/s40257-020-00584-2

Bilgin H, Ozcan B, Bilgin T. Methemoglobinemia induced by methylene blue pertubation during

laparoscopy. Acta Anaesthesiol Scand. 1998;42(5):594-5. doi: 10.1111/j.1399-6576.1998.tb05173.x

Antiga E, Caproni M. The diagnosis and treatment of dermatitis herpetiformis. Clin Cosmet Investig

Dermatol. 2015;8:257-65. doi: 10.2147/CCID.S69127

Albers LN, Zone JJ, Stoff BK, Feldman RJ. Rituximab Treatment for Recalcitrant Dermatitis Herpetiformis.

JAMA Dermatol. 2017;153(3):315-8. doi: 10.1001/jamadermatol.2016.4676

Cinats AK, Parsons LM, Haber RM. Facial Involvement in Dermatitis Herpetiformis: A Case Report and

Review of the Literature. J Cutan Med Surg. 2019;23(1):35-7. doi: 10.1177/1203475418795818

Downloads

  • PDF

Published

2024-12-20

How to Cite

1.
ZWARDOŃ, Jakub, KAPCIAK, Alicja, GÓRNY, Julia, WITAS, Gabriela, HAWAJSKI, Artur, JANKOWSKA, Natalia, KAMIENIECKA, Oliwia, NAJA, Katarzyna and ŚWIERZYŃSKA, Adrianna. Is a gluten-free diet sufficient in the treatment of Duhring’s Disease? - A Review. Quality in Sport. Online. 20 December 2024. Vol. 36, p. 56447. [Accessed 12 June 2025]. DOI 10.12775/QS.2024.36.56447.
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 36 (2024)

Section

Medical Sciences

License

Copyright (c) 2024 Jakub Zwardoń, Alicja Kapciak, Julia Górny, Gabriela Witas, Artur Hawajski, Natalia Jankowska, Oliwia Kamieniecka, Katarzyna Naja, Adrianna Świerzyńska

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Stats

Number of views and downloads: 117
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

dermatitis herpetiformis, celiac disease, gluten free diet, direct immunofluorescence, dapsone, sulfonamides
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Instytut Tomistyczny
  • Karmelitański Instytut Duchowości w Krakowie
  • Ministerstwo Kultury i Dziedzictwa Narodowego
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polska Fundacja Przemysłu Kosmicznego
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop